Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walker

Showing results (351-360 of 568) with videos related to

Pageof 57
Sort By:
Antibiotics (Basel, Switzerland)|December 4, 2020
Social and Contextual Influences on Antibiotic Prescribing and Antimicrobial Stewardship: A Qualitative Study with Clinical Commissioning Group and General Practice ProfessionalsAleksandra J Borek, Sibyl Anthierens, Rosalie Allison, et al.
Journal of Clinical Microbiology|July 29, 2020
DNA Thermo-Protection Facilitates Whole-Genome Sequencing of Mycobacteria Direct from Clinical SamplesSophie George, Yifei Xu, Gillian Rodger, et al.
Mbio|April 5, 2023
Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficileKate E Dingle, Jane Freeman, Xavier Didelot, et al.
BMJ Open|April 8, 2024
Social prescribing for people living with dementia (PLWD) and their carers: what works, for whom, under what circumstances and why - protocol for a complex intervention systematic reviewJessica Marshall, Evie Papavasiliou, Chris Fox, et al.
BMC Medicine|July 31, 2020
Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment surveyLaurence S J Roope, James Buchanan, Liz Morrell, et al.
Jac-Antimicrobial Resistance|March 19, 2024
Prediction of pyrazinamide resistance in <i>Mycobacterium tuberculosis</i> using structure-based machine-learning approachesJoshua J Carter, Timothy M Walker, A Sarah Walker, et al.
The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.
Nature Communications|October 1, 2025
Escherichia coli phylogeny drives co-amoxiclav resistance through variable expression of TEM-1 beta-lactamaseWilliam Matlock, Gillian Rodger, Emma Pritchard, et al.
Plos Medicine|February 21, 2012
Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typingA Sarah Walker, David W Eyre, David H Wyllie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2017
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan AfricaCissy Kityo, Jennifer Thompson, Immaculate Nankya, et al.
Pageof 57

Showing results (351-360 of 568) with videos related to

Sort By:
Pageof 57
Antibiotics (Basel, Switzerland)|December 4, 2020
Social and Contextual Influences on Antibiotic Prescribing and Antimicrobial Stewardship: A Qualitative Study with Clinical Commissioning Group and General Practice ProfessionalsAleksandra J Borek, Sibyl Anthierens, Rosalie Allison, et al.
Journal of Clinical Microbiology|July 29, 2020
DNA Thermo-Protection Facilitates Whole-Genome Sequencing of Mycobacteria Direct from Clinical SamplesSophie George, Yifei Xu, Gillian Rodger, et al.
Mbio|April 5, 2023
Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficileKate E Dingle, Jane Freeman, Xavier Didelot, et al.
BMJ Open|April 8, 2024
Social prescribing for people living with dementia (PLWD) and their carers: what works, for whom, under what circumstances and why - protocol for a complex intervention systematic reviewJessica Marshall, Evie Papavasiliou, Chris Fox, et al.
BMC Medicine|July 31, 2020
Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment surveyLaurence S J Roope, James Buchanan, Liz Morrell, et al.
Jac-Antimicrobial Resistance|March 19, 2024
Prediction of pyrazinamide resistance in <i>Mycobacterium tuberculosis</i> using structure-based machine-learning approachesJoshua J Carter, Timothy M Walker, A Sarah Walker, et al.
The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.
Nature Communications|October 1, 2025
Escherichia coli phylogeny drives co-amoxiclav resistance through variable expression of TEM-1 beta-lactamaseWilliam Matlock, Gillian Rodger, Emma Pritchard, et al.
Plos Medicine|February 21, 2012
Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typingA Sarah Walker, David W Eyre, David H Wyllie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2017
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan AfricaCissy Kityo, Jennifer Thompson, Immaculate Nankya, et al.
Pageof 57